These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2005388)
1. Passive transfer of local immunity to influenza virus infection by IgA antibody. Renegar KB; Small PA J Immunol; 1991 Mar; 146(6):1972-8. PubMed ID: 2005388 [TBL] [Abstract][Full Text] [Related]
2. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112 [TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. Renegar KB; Jackson GD; Mestecky J J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537 [TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. Mbawuike IN; Pacheco S; Acuna CL; Switzer KC; Zhang Y; Harriman GR J Immunol; 1999 Mar; 162(5):2530-7. PubMed ID: 10072492 [TBL] [Abstract][Full Text] [Related]
5. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. Kris RM; Asofsky R; Evans CB; Small PA J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963 [TBL] [Abstract][Full Text] [Related]
7. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010 [TBL] [Abstract][Full Text] [Related]
8. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. Asahi-Ozaki Y; Yoshikawa T; Iwakura Y; Suzuki Y; Tamura S; Kurata T; Sata T J Med Virol; 2004 Oct; 74(2):328-35. PubMed ID: 15332283 [TBL] [Abstract][Full Text] [Related]
9. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant. Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854 [TBL] [Abstract][Full Text] [Related]
10. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. Renegar KB; Small PA; Boykins LG; Wright PF J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932 [TBL] [Abstract][Full Text] [Related]
11. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. Nagai T; Yamada H Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672 [TBL] [Abstract][Full Text] [Related]
12. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant. Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590 [TBL] [Abstract][Full Text] [Related]
13. Influenza virus infection of the murine uterus: a new model for antiviral immunity in the female reproductive tract. Renegar KB; Menge A; Mestecky J Viral Immunol; 2006; 19(4):613-22. PubMed ID: 17201656 [TBL] [Abstract][Full Text] [Related]
14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
15. Influenza: pathogenesis and host defense. Bender BS; Small PA Semin Respir Infect; 1992 Mar; 7(1):38-45. PubMed ID: 1609166 [TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related]
17. Impairment of mucosal immunity by parenteral nutrition: depressed nasotracheal influenza-specific secretory IgA levels and transport in parenterally fed mice. Renegar KB; Kudsk KA; Dewitt RC; Wu Y; King BK Ann Surg; 2001 Jan; 233(1):134-8. PubMed ID: 11141235 [TBL] [Abstract][Full Text] [Related]
18. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies. Tanimoto T; Haredy AM; Takenaka N; Tamura S; Okuno Y; Mori Y; Yamanishi K; Okamoto S Viral Immunol; 2012 Oct; 25(5):433-9. PubMed ID: 22985289 [TBL] [Abstract][Full Text] [Related]
20. Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. Mazanec MB; Nedrud JG; Liang XP; Lamm ME J Immunol; 1989 Jun; 142(12):4275-81. PubMed ID: 2542407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]